Related Experiment Video
Updated: May 25, 2026
Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023
Microenvironment changes in mild traumatic brain injury
Enci Mary Kan1, Eng-Ang Ling, Jia Lu
1Combat Care Laboratory, Defence Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Drive, Singapore 117510, Singapore.
Abstract:
Traumatic brain injury (TBI) is a major public-health problem for which mild TBI (MTBI) makes up majority of the cases. MTBI is a poorly-understood health problem and can persist for years manifesting into neurological and non-neurological problems that can affect functional outcome. Presently, diagnosis of MTBI is based on symptoms reporting with poor understanding of ongoing pathophysiology, hence precluding prognosis and intervention. Other than rehabilitation, there is still no pharmacological treatment for the treatment of secondary injury and prevention of the development of cognitive and behavioural problems. The lack of external injuries and absence of detectable brain abnormalities lend support to MTBI developing at the cellular and biochemical level. However, the paucity of suitable and validated non-invasive methods for accurate diagnosis of MTBI poses as a substantial challenge. Hence, it is crucial that a clinically useful evaluation and management procedure be instituted for MTBI that encompasses both molecular pathophysiology and functional outcome. The acute microenvironment changes post-MTBI presents an attractive target for modulation of MTBI symptoms and the development of cognitive changes later in life.
Insights
Mild traumatic brain injury (MTBI) is a common yet poorly understood condition. New diagnostic methods are needed to understand its cellular effects and improve patient outcomes.
Area of Science:
- Neuroscience
- Neurology
- Public Health
Background:
- Mild traumatic brain injury (MTBI) constitutes the majority of traumatic brain injuries (TBIs) and presents significant public health challenges.
- Current MTBI diagnosis relies on subjective symptom reporting, lacking insight into underlying pathophysiology, which hinders effective prognosis and intervention.
- The absence of external signs and detectable brain abnormalities suggests MTBI impacts the brain at a cellular and biochemical level.
Purpose of the Study:
- To highlight the critical need for advanced diagnostic tools for MTBI.
- To emphasize the importance of understanding MTBI's molecular pathophysiology for improved clinical management.
- To identify the acute microenvironment post-MTBI as a potential therapeutic target.
Main Methods:
- Review of current diagnostic limitations for MTBI.
- Analysis of the cellular and biochemical changes associated with MTBI.
- Exploration of the potential of targeting the acute microenvironment for therapeutic intervention.
Main Results:
- MTBI diagnosis is currently limited by a lack of objective, non-invasive methods.
- Cellular and biochemical alterations are key to understanding MTBI's persistent effects.
- The post-MTBI microenvironment presents a promising target for mitigating symptoms and cognitive decline.
Conclusions:
- There is a crucial need for clinically applicable evaluation and management procedures for MTBI.
- These procedures must integrate molecular pathophysiology with functional outcome assessment.
- Modulating the acute microenvironment post-MTBI may offer a pathway to prevent long-term cognitive and behavioral issues.
More Related Videos
08:27Development of an Uncomplicated Mild Traumatic Brain Injury Model Modified by Weight-Drop Method and Evidenced by Magnetic Resonance Imaging
Published on: April 11, 2025
04:54Modified Mouse Model of Repetitive Mild Traumatic Brain Injury Incorporating Thinned-Skull Window and Fluid Percussion
Published on: April 19, 2024
